S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 121 to 180 of 523

Issue Date	Title / Author(s) / Citation	File
2006-04	Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients Park, Y. H.; Lee, J. J.; Ryu, M. H.; Kim, S. Y.; Kim, D. H.; Do, Y. R.; Lee, K. H.; Oh, S. J.; Kim, Y. K.; Suh, C. W.; Heo, D. S.; RYoo, B. Y.; Kim, J. K.; Song, H. S.; Lee, W. S.; Kim, H. J.; Bang, Y. J.; Yang, S. H.; Sohn, S. K.; Kang, Y. K. Annals of Hematology, Vol.85 No.4, pp.257-262	DOI
2006-04	Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1,2 and PI3K/Akt Kim, SH; Juhnn, YS; Kang, S; Park, SW; Sung, MW; Bang, YJ; Song, YS Cellular and Molecular Life Sciences, Vol.63 No.7-8, pp.930-938	DOI
2006-04	Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation Han, Sae-Won; Kim, Tae-You; Jeon, Young Kyung; Hwang, Pil Gyu; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Dong-Wan; Heo, Dae-Seog; Kim, Noe Kyeong; Chung, Doo Hyun; Bang, Yung-Jue Clinical Cancer Research, Vol.12 No.8, pp.2538-2544	DOI
2006-06	Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer Lee, Kyung-Hun; Han, Sae-Won; Hwang, Pil Gyu; Oh, Do-Youn; Kim, Dong-Wan; Chung, Doo Hyun; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.36 No.6, pp.344-350	DOI
2006-07	First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Heo, Dae Seog; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyeong Leukemia and Lymphoma, Vol.47 No.7, pp.1274-1282	DOI
2006-07	High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy Lee, Kyung-Hun; Lee, Se-Hoon; Kim, Dong-Wan; Kang, Won Jun; Chung, June-Key; Im, Seock-Ah; Kim, Tae-You; Kim, Young Whan; Bang, Yung-Jue; Heo, Dae Seog Clinical Cancer Research, Vol.12 No.14, pp.4232-4236	DOI
2006-08	Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome Park, Sook Ryun; Baek, Ji Yeon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Kim, Noe Kyeong; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog Journal of Korean Medical Science, Vol.21 No.4, pp.633-638	view file DOI
2006-09	Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells Lee, Keun-Wook; Kim, Jee Hyun; Park, Jung-Hyun; Kim, Hwang-Phill; Song, Sang-Hyun; Kim, Sang Gyun; Kim, Tai Young; Jong, Hyun-Soon; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Noe Kyeong; Bang, Yung-Jue Anticancer Research, Vol.26 No.5A, pp.3429-3438
2006-11	Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.54 No.2, pp.201-207	DOI
2006-12	Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells Lee, Ju-Hee; Park, Jung-Hyun; Jung, Yeonjoo; Kim, Jee-Hyun; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.5 No.12, pp.3085-3095	DOI
2007-03	DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma Kim, Tai Young; Lee, Jung Weon; Kim, Hwang-Phill; Jong, Hyun-Soon; Kim, Tae-You; Jung, Mira; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.355 No.1, pp.72-77	DOI
2007-04	Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Kim, Hwang-Phill; Park, Jung-Hyun; Jung, Yeonjoo; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Biochemical and Biophysical Research Communications, Vol.355 No.2, pp.318-323	DOI
2007-04	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy Lee, Kyung-Hun; Im, Seock-Ah; Oh, Do-Youn; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 63	view file DOI
2007-05	Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer Han, Sae-Won; Jeon, Yoon Kyung; Lee, Kyung-Hun; Keam, Bhumsuk; Hwang, Pil Gyu; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Pharmacogenetics and Genomics, Vol.17 No.5, pp.313-319	DOI
2007-06	Artificial nutrition and hydration in terminal cancer patients: the real and the ideal Oh, Do Youn; Kim, Jee Hyun; Lee, Se Hoon; Kim, Dong Wan; Im, Seock-Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung Jue; Kim, Noe Kyeong Supportive Care in Cancer, Vol.15 No.6, pp.631-636	DOI
2007-07	Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial Kim, Yeul Hong; Yamaguchi, Kensei; Bang, Yung-Jue; Takiuchi, Hiroya; Kang, Won Ki; Sato, Atsushi; Kang, Yoon-Koo; Sakamoto, Junichi; Abe, Chigusa; Sakata, Yuh Japanese Journal of Clinical Oncology, Vol.37 No.7, pp.501-508	DOI
2007-09	Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer Lee, Keun-Wook; Kim, Jee Hyun; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hytinchoon; Oh, So Yeon; Choi, In Sil; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.22, pp.S115-S121	view file
2007-10	Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy Jung, Yeonjoo; Park, Jinah; Kim, Tai Young; Park, Jung-Hyun; Jong, Hyun-Soon; Im, Seock-Ah; Robertson, Keith D.; Bang, Yung-Jue; Kim, Tae-You Journal of Molecular Medicine, Vol.85 No.10, pp.1137-1148	DOI
2007-11	Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives Kim, Toe-You; Han, Soe-Won; Bang, Yung-Jue Expert Review of Molecular Diagnostics, Vol.7 No.6, pp.821-836	DOI
2007-11	Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer Chie, Eui Kyu; Kim, Kyubo; Noh, Dong-Young; Choe, Kuk Jin; Kim, Tae-You; Im, Seok-Ah; Bang, Yung-Jue; Ha, Sung W. Tumori, Vol.93 No.6, pp.591-596	DOI
2007-11	Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer Keam, Bhumsuk; Im, Seock-Ah; Kim, Hee-Jun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.7, p. 203	view file DOI
2008	DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Park, Jung-Hyun; Kim, Hwang-Phill; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2462-2471	DOI
2008	Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Lee, Ju-Hee; Park, Jung-Hyun; Streb, Jeffrey W.; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2534-2543	DOI
2008-01	Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase Park, Jung-Hyun; Jong, Hyun-Soon; Kim, Sang Gyun; Jung, Yeonjoo; Lee, Keun-Wook; Lee, Ju-Hee; Kim, Dae-Kee; Bang, Yung-Jue; Kim, Tae-You Journal of Molecular Medicine, Vol.86 No.1, pp.117-128	DOI
2008-01	A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer Kim, Y. J.; Im, S. -A.; Kim, H. G.; Oh, S. Y.; Lee, K. W.; Choi, I. S.; Oh, D. Y.; Lee, S. H.; Kim, J. H.; Kim, D. W.; Kim, T. Y.; Kim, S. W.; Heo, D. S.; Yoon, Y. B.; Bang, Y. J. Annals of Oncology, Vol.19 No.1, pp.99-103	DOI
2008-01	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin Kim, Sun Young; Kim, Hwang Phill; Kim, Yu Jung; Oh, Do Youn; Im, Seock-Ah; Lee, Dongsoon; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue International Journal of Oncology, Vol.32 No.1, pp.89-95	DOI
2008-02	Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer Kim, Yu Jung; Kim, Min A.; Im, Seock-Ah; Kim, Tae Min; Kim, Dong-Wan; Yang, Han-Kwang; Heo, Dae Seog; Lee, Kuhn-Uk; Choe, Kuk Jin; Kim, Noe Kyeong; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Investigation, Vol.26 No.2, pp.152-158	DOI
2008-02	Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers Jung, Yeonjoo; Park, Jinah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.88 No.2, pp.153-160	DOI
2008-03	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, H. S.; Lee, K-H; Kim, Y. J.; Oh, D-Y; Jeon, Y. K.; Lee, S. -H.; Im, S. -A.; Chung, D. H.; Kim, Y. T.; Kim, T. -Y.; Bang, Y. -J.; Sung, S. W.; Kim, J. H.; Heo, D. S. British Journal of Cancer, Vol.98 No.6, pp.1118-1124	DOI
2008-03	Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells Kim, Hwang-Phill; Han, Sae-Won; Kim, Sung-Hak; Im, Seock-Ah; Oh, Do-Youn; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.7 No.3, pp.607-615	DOI
2008-03	Enzastaurin, a protein kinase Cβ inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells Lee, Keun-Wook; Kim, Sang Gyun; Kim, Hwang-Phill; Kwon, Euna; Yons, Jiran; Choi, Hyung-Jun; Park, Jung-Hyun; Kang, Byeong-Cheol; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Research, Vol.68 No.6, pp.1916-1926	DOI
2008-04	Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors Park, Jung-Hyun; Kim, Sung-Hak; Choi, Moon-Chang; Lee, Juhee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Biochemical and Biophysical Research Communications, Vol.368 No.2, pp.318-322	DOI
2008-05	Aggressiveness of cancer-care near the end-of-life in Korea Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386	DOI
2008-05	DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms Healy, Kevin D.; Hodgson, Louis; Kim, Tai-Young; Shutes, Adam; Maddileti, Savitri; Juliano, Rudolph L.; Hahn, Klaus M.; Harden, T. Kendall; Bang, Yung-Jue; Der, Channing J. Molecular Carcinogenesis, Vol.47 No.5, pp.326-337	DOI
2008-05	A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Molecular Medicine Reports, Vol.1 No.3, pp.415-422	DOI
2008-05	Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker Keam, Bhumsuk; Im, Seock-Ah; Han, Sae-Won; Ham, Hye Seon; Kim, Min A.; Oh, Do-Youn; Lee, Se-Hoon; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Kim, Woo Ho; Bang, Yung-Jue BMC Cancer, Vol.8, p. 148	view file DOI
2008-06	ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer Lee, Kyung-Hun; Min, Hye Sook; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Young Tae; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Kim, Joo Hyun Lung Cancer, Vol.60 No.3, pp.401-407	DOI
2008-06	Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer Lee, Hyo-Pyo; Seo, Sang-Soo; Ryu, Sang-Young; Kim, Jong-Hyeok; Bang, Yung-Jue; Park, Sang-Yoon; Nam, Joo-Hyun; Kang, Soon-Beorn; Lee, Kyung-Hee; Song, Yong Sang Gynecologic Oncology, Vol.109 No.3, pp.359-363	DOI
2008-06	Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer Kim, Hye Jin; Kim, Jin-Soo; Seo, Myung-Deok; Oh, So-Yeon; Oh, Do Youn; Kim, Jee Hyun; 이세훈; Kim, Dong Wan; Im, Seock Ah; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.40 No.2, pp.81-86
2008-07	Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study Kim, Yeul Hong; Chung, Hyun Cheol; Kang, Won Ki; Park, Sook Ryun; Kim, Chul Soo; Kim, Tae-Yue; Shin, Sang Won; Park, Byung-Joo; Cha, Soo Jin; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.62 No.2, pp.263-270	DOI
2008-07	Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01 Fujitani, Kazumasa; Yang, Han-Kwang; Kurokawa, Yukinori; Park, Do Joong; Tsujinaka, Toshimasa; Park, Byung-Joo; Fukuda, Haruhiko; Noh, Sung Hoon; Boku, Narikazu; Bang, Yung-Jue; Sasako, Mitsuru; Lee, Jong-Inn Japanese Journal of Clinical Oncology, Vol.38 No.7, pp.504-506	DOI
2008-07	Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment Han, Sae-Won; Kim, Hwang-Phill; Jeon, Yoon Kyung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Heo, Dae Seog; Bang, Yung-Jue; Kim, Tae-You Lung Cancer, Vol.61 No.1, pp.30-34	DOI
2008-08	A-kinase anchoring protein 12 regulates the completion of cytokinesis Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Park, Jung-Hyun; Kim, Hyun-Ah; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.373 No.1, pp.85-89	DOI
2008-09	Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer Seo, Myung-Deok; Lee, Keun-Wook; Lim, Joo Han; Yi, Hyeon Gyu; Kim, Dae-Young; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.38 No.9, pp.589-595	DOI
2008-10	Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study Rothenberg, M. L.; Cox, J. V.; Butts, C.; Navarro, M.; Bang, Y. -J.; Goel, R.; Gollins, S.; Siu, L. L.; Laguerre, S.; Cunningham, D. Annals of Oncology, Vol.19 No.10, pp.1720-1726	DOI
2008-10	The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue; Kim, Tae-You BMC Cancer, Vol.8, p. 307	view file DOI
2008-11	Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives Kim, J. W.; Kim, S. -J.; Chung, Y. -H.; Kwon, J. -H.; Lee, H. -J.; Chung, Y. -J.; Kim, Y. J.; Oh, Do-Youn; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Heo, D. S.; Bang, Y. -J. British Journal of Cancer, Vol.99 No.10, pp.1593-1599	DOI
2008-11	Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration Kim, Tai Young; Healy, Kevin D.; Der, Channing J.; Sciaky, Noah; Bang, Yung-Jue; Juliano, Rudy L. Journal of Biological Chemistry, Vol.283 No.47, pp.32762-32770	DOI
2008-11	DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1 Park, Jinah; Kim, Tae-You; Jung, Yeonjoo; Song, Sang-Hyun; Kim, Sung-Hak; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue Journal of Molecular Medicine, Vol.86 No.11, pp.1269-1277	DOI
2008-12	Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells Kim, Tai Young; Kim, In Sook; Jong, Hyun-Soon; Lee, Jung Weon; Kim, Tae-You; Jung, Mira; Bang, Yung-Jue Experimental and Molecular Medicine, Vol.40 No.6, pp.639-646	DOI
2008-12	The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines Kim, Jin Won; Kim, Hwang-Phill; Im, Seock-Ah; Kang, Soyeong; Hur, Hyung Seok; Yoon, Young-Kwang; Oh, Do-Youn; Kim, Jee Hyun; Lee, Dong Soon; Kim, Tae-You; Bang, Yung-Jue Cancer Letters, Vol.272 No.2, pp.296-306	DOI
2008-12	Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study Kim, Mi-Jung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.8, p. 374	view file DOI
2009	Kinase Mutations and Efficacy of Imatinib in Korean Patients with Advanced Gastrointestinal Stromal Tumors Kim, Tae Won; Ryu, Min-Hee; Lee, Heungnam; Sym, Sun Jin; Lee, Jae-Lyun; Chang, Heung Moon; Park, Young Suk; Lee, Kyung Hee; Kang, Won Ki; Shin, Dong Bok; Bang, Yung-Jue; Lee, Jung Shin; Kang, Yoon-Koo Oncologist, Vol.14 No.5, pp.540-547	DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2009-01	Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone Kim, B. -S.; Kim, D. -W.; Im, S. -A.; Kim, C. W.; Kim, T. -Y.; Yoon, S. -S.; Heo, D. S.; Bang, Y. -J.; Park, S.; Kim, B. K.; Kim, N. K. Annals of Oncology, Vol.20 No.1, pp.121-128	DOI
2009-02	Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Japanese Journal of Clinical Oncology, Vol.39 No.2, pp.111-115	DOI
2009-03	Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival Kim, J. -S.; Kim, M. -A.; Kim, T. M.; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Kim, W. H.; Yang, H. -K.; Heo, D. S.; Bang, Y. -J.; Lee, K. -U.; Choe, K. -J.; Kim, N. K. British Journal of Cancer, Vol.100 No.5, pp.732-738	DOI
2009-03	The role of PET/CT in detection of gastric cancer recurrence Sim, Sung Hoon; Kim, Yu Jung; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kang, Won Jun; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Heo, Dae Seog; Bang, Yung-Jue BMC Cancer, Vol.9, p. 73	view file DOI
2009-04	A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor Ryu, Min-Hee; Kang, Won Ki; Bang, Yung-Jue; Lee, Kyung Hee; Shin, Dong Bok; Ryoo, Baek-Yeol; Roh, Jae Kyung; Kang, Jin-Hyoung; Lee, Hyoungnam; Kim, Tae Won; Chang, Heung Moon; Park, Joon Oh; Park, Young Suk; Kim, Tae-You; Kim, Min Kyoung; Lee, Woon Kee; Kang, Hye Jin; Kang, Yoon-Koo Oncology, Vol.76 No.5, pp.326-332	DOI
2009-05	Involvement of NF-κB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein Kim, Su-Hyeong; Oh, Jung-Min; No, Jae-Hong; Bang, Yung-Jue; Juhnn, Yong-Sung; Song, Yong-Sang Carcinogenesis, Vol.30 No.5, pp.753-757	DOI

1 2 3 4 5 6 9